<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1831">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04563676</url>
  </required_header>
  <id_info>
    <org_study_id>PI2020_843_0096</org_study_id>
    <nct_id>NCT04563676</nct_id>
  </id_info>
  <brief_title>Physiopathology and Sequelae of COVID-19 Infection</brief_title>
  <acronym>SEQ-COV-PHYSIO</acronym>
  <official_title>Physiopathology and Sequelae of COVID-19 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The data obtained from Covid-19 infections seem to suggest that the immunogenesis of Covid-19
      could in some cases be the result of immune dysregulation. On the other hand, endocrine
      damage is possible at the tile of Covid-19 infection (mainly thyroid,adrenal, and
      hypothalamus). These disorders are autoimmune or linked to degeneration.

      The main objective is to assess the thyroid function (thyrotropic axis) as well as the
      corticotropic adrenal function of patients who have had Copvid-19 pneumonia. The secondary
      objectives is to describe the pathophysiological mechanisms of pulmonary and
      vasculothrombotic involvement of Covid-19
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>8-hour cortisol level in patients with Covid19 pneumonia</measure>
    <time_frame>day 0</time_frame>
    <description>8-hour cortisol level in patients with Covid19 pneumonia will be determined the day of consultation for respiratory sequelae.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TSH level in patients with Covid19 pneumonia</measure>
    <time_frame>day 0</time_frame>
    <description>TSH level in patients with Covid19 pneumonia will be determined the day of consultation for respiratory sequelae.</description>
  </primary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Covid19</condition>
  <condition>TSH</condition>
  <condition>Cortisol</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood test</intervention_name>
    <description>covid19 infected patient will have a blood test in order to make an autoimmune assessment (antinuclear antibodies, soluble nuclear anti-antigen, ANCA, antiphospholipid antibodies, FT3, FT4 , TSH, antithyroid antibodies, ACTH cortisol, and creation of a serotheque).</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient having a covid19 infection hospitalized at the Amiens Picardie University
             Hospital

          -  Patient who is seen in Pneumology consultation for a respiratory assessment at 3
             months of his hospitalization (between M2 and M4) to evaluate presence of respiratory
             sequelae

          -  Patient who agreed to participate in the protocol

          -  Patient affiliated to a Social Security

        Exclusion Criteria:

          -  patient under guardianship or curators

          -  patient refusing to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claire ANDREJAK, Pr</last_name>
    <phone>(33)3.22.08.79.98</phone>
    <email>andrejak.claire@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire ANDREJAK, Pr</last_name>
      <phone>(33)3.22.08.79.98</phone>
      <email>andrejak.claire@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Valery Salle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachel DESAILLOUD, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 23, 2020</study_first_submitted>
  <study_first_submitted_qc>September 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2020</study_first_posted>
  <last_update_submitted>September 23, 2020</last_update_submitted>
  <last_update_submitted_qc>September 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Covid19</keyword>
  <keyword>TSH</keyword>
  <keyword>cortisol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

